{"id":33093,"date":"2024-09-24T15:47:53","date_gmt":"2024-09-24T19:47:53","guid":{"rendered":"https:\/\/avalere.com\/?p=33093"},"modified":"2024-10-11T16:46:11","modified_gmt":"2024-10-11T20:46:11","slug":"exploring-rna-based-therapies-innovations-and-impact","status":"publish","type":"post","link":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact","title":{"rendered":"Exploring RNA-Based Therapies: Innovations and Impact"},"content":{"rendered":"<p>These innovative products leverage genetically targeted technologies and raise key regulatory and policy questions that our panelists will explore. This conversation will:<\/p>\n<ul>\n<li>Clarify how innovative biotechnologies that leverage RNA are classified.<\/li>\n<li>Explore the current development landscape for RNA-based therapies.<\/li>\n<li>Address how the commercialization environment affects RNA products relative to other innovative biotechnologies.<\/li>\n<li>Offer forward-looking perspectives on patient access and policies influencing emerging therapies.<\/li>\n<li>Learn which diseases with unmet needs will benefit from Genetically Targeted Therapies (or RNA-based therapies.)<\/li>\n<\/ul>\n<p>In May, Avalere produced a report focused on the future development for RNA-based therapies as a class of medications. Read more here: <em>\u00a0<u><a href=\"https:\/\/urldefense.com\/v3\/__https:\/avalere.com\/wp-content\/uploads\/2024\/06\/20240522-Lilly-RNA-Based-Therapies-White-Paper-vFINAL.pdf__;!!A_kSX19cfVk!Fxqf9M6CRy4ILuJDQRgtV85BdHfGZkZMvynzJhGjp2uIFYf7ENKf5aOeRNsN6aa11b0dHXfrS5F5nRu22lPvhR3EvMT-wQ$\">Overview and Outlook for RNA-Based Therapies<\/a><\/u><\/em><\/p>\n<p>&nbsp;<\/p>\n<p><em><span class=\"ui-provider a b c d e f g h i j k l m n o p q r s t u v w x y z ab ac ae af ag ah ai aj ak\" dir=\"ltr\">Panelist views are their own \u2013 they do not represent the views or positions of Avalere or Eli Lilly.\u00a0<\/span><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>These innovative products leverage genetically targeted technologies and raise key regulatory and policy questions that our panelists will explore. This conversation will: Clarify how innovative biotechnologies that leverage RNA are classified. Explore the current development landscape for RNA-based therapies. Address how the commercialization environment affects RNA products relative to other innovative biotechnologies. Offer forward-looking perspectives&hellip;<\/p>\n","protected":false},"author":17,"featured_media":20618,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"content-categories":[891],"class_list":["post-33093","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-webinars","content-categories-fda-regulatory-pathways","entry","has-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Exploring RNA-Based Therapies: Innovations and Impact | Avalere Health Advisory<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exploring RNA-Based Therapies: Innovations and Impact | Avalere Health Advisory\" \/>\n<meta property=\"og:description\" content=\"These innovative products leverage genetically targeted technologies and raise key regulatory and policy questions that our panelists will explore. This conversation will: Clarify how innovative biotechnologies that leverage RNA are classified. Explore the current development landscape for RNA-based therapies. Address how the commercialization environment affects RNA products relative to other innovative biotechnologies. Offer forward-looking perspectives&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact\" \/>\n<meta property=\"og:site_name\" content=\"Avalere Health Advisory\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-24T19:47:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-11T20:46:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2020\/09\/15857-1-Nicole_Meyerson-400x600-1-e1600631821350.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cturner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@avalerehealth\" \/>\n<meta name=\"twitter:site\" content=\"@avalerehealth\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cturner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exploring RNA-Based Therapies: Innovations and Impact | Avalere Health Advisory","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact","og_locale":"en_US","og_type":"article","og_title":"Exploring RNA-Based Therapies: Innovations and Impact | Avalere Health Advisory","og_description":"These innovative products leverage genetically targeted technologies and raise key regulatory and policy questions that our panelists will explore. This conversation will: Clarify how innovative biotechnologies that leverage RNA are classified. Explore the current development landscape for RNA-based therapies. Address how the commercialization environment affects RNA products relative to other innovative biotechnologies. Offer forward-looking perspectives&hellip;","og_url":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact","og_site_name":"Avalere Health Advisory","article_published_time":"2024-09-24T19:47:53+00:00","article_modified_time":"2024-10-11T20:46:11+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2020\/09\/15857-1-Nicole_Meyerson-400x600-1-e1600631821350.jpg","type":"image\/jpeg"}],"author":"cturner","twitter_card":"summary_large_image","twitter_creator":"@avalerehealth","twitter_site":"@avalerehealth","twitter_misc":{"Written by":"cturner","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact#article","isPartOf":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact"},"author":{"name":"cturner","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/person\/8cbb93ca150560eaa45e177128d2a9a9"},"headline":"Exploring RNA-Based Therapies: Innovations and Impact","datePublished":"2024-09-24T19:47:53+00:00","dateModified":"2024-10-11T20:46:11+00:00","mainEntityOfPage":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact"},"wordCount":131,"commentCount":0,"publisher":{"@id":"https:\/\/advisory.avalerehealth.com\/#organization"},"image":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact#primaryimage"},"thumbnailUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2020\/09\/15857-1-Nicole_Meyerson-400x600-1-e1600631821350.jpg","articleSection":["Webinars"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact#respond"]}]},{"@type":"WebPage","@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact","url":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact","name":"Exploring RNA-Based Therapies: Innovations and Impact | Avalere Health Advisory","isPartOf":{"@id":"https:\/\/advisory.avalerehealth.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact#primaryimage"},"image":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact#primaryimage"},"thumbnailUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2020\/09\/15857-1-Nicole_Meyerson-400x600-1-e1600631821350.jpg","datePublished":"2024-09-24T19:47:53+00:00","dateModified":"2024-10-11T20:46:11+00:00","breadcrumb":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact#primaryimage","url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2020\/09\/15857-1-Nicole_Meyerson-400x600-1-e1600631821350.jpg","contentUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2020\/09\/15857-1-Nicole_Meyerson-400x600-1-e1600631821350.jpg","width":600,"height":400,"caption":"Nicole Meyerson"},{"@type":"BreadcrumbList","@id":"https:\/\/advisory.avalerehealth.com\/webinars\/exploring-rna-based-therapies-innovations-and-impact#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/advisory.avalerehealth.com\/"},{"@type":"ListItem","position":2,"name":"Exploring RNA-Based Therapies: Innovations and Impact"}]},{"@type":"WebSite","@id":"https:\/\/advisory.avalerehealth.com\/#website","url":"https:\/\/advisory.avalerehealth.com\/","name":"Avalere Health Advisory","description":"","publisher":{"@id":"https:\/\/advisory.avalerehealth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/advisory.avalerehealth.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/advisory.avalerehealth.com\/#organization","name":"Avalere Health","url":"https:\/\/advisory.avalerehealth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/logo\/image\/","url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2025\/03\/avalere-health-logo-cropped-white_1x.webp","contentUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2025\/03\/avalere-health-logo-cropped-white_1x.webp","width":433,"height":47,"caption":"Avalere Health"},"image":{"@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/avalerehealth"]},{"@type":"Person","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/person\/8cbb93ca150560eaa45e177128d2a9a9","name":"cturner","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fbae6a0a1ad4084cd85b62cfb6863eee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fbae6a0a1ad4084cd85b62cfb6863eee?s=96&d=mm&r=g","caption":"cturner"},"url":"https:\/\/advisory.avalerehealth.com\/author\/cturner"}]}},"_links":{"self":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts\/33093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/comments?post=33093"}],"version-history":[{"count":19,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts\/33093\/revisions"}],"predecessor-version":[{"id":33322,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts\/33093\/revisions\/33322"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/media\/20618"}],"wp:attachment":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/media?parent=33093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/categories?post=33093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/tags?post=33093"},{"taxonomy":"content-categories","embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/content-categories?post=33093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}